CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)	Total	Additional Paid-In Capital	Accumulated Other Comprehensive Income	Accumulated Deficit	Common Stock
Beginning Balance, Shares at Sep. 30, 2017					224,426,229
Beginning Balance, Amount at Sep. 30, 2017	$ (849,394)	$ 5,888,210		$ (6,739,849)	$ 2,245
Shares issued in connection with the sale of common stock, Shares					3,208,586
Foreign currency translation adjustment	69,742		69,742
Net Loss	(1,953,822)			(1,953,822)
Stock-based compensation expense, Shares					8,200,000
Shares issued for debt, Shares					50,000
Related party debt forgiveness	25,800	25,800
Shares issued in connection with the sale of common stock, Amount	352,909	352,877			32
Stock-based compensation expense, Amount	1,206,412	1,206,330			82
Shares issued for debt, Amount	60,730	60,730
Ending Balance, Shares at Mar. 31, 2018					234,242,896
Ending Balance, Amount at Mar. 31, 2018	(1,075,135)	7,360,968		(8,438,446)	$ 2,343
Shares issued in connection with the sale of common stock, Shares					1,591,919
Foreign currency translation adjustment	69,742		69,742
Net Loss	(255,225)			(255,225)
Shares issued for debt, Shares					50,000
Shares issued in connection with the sale of common stock, Amount	112,265	112,249			$ 16
Shares issued for debt, Amount	60,730	60,730
Ending Balance, Shares at Jun. 30, 2018					235,884,815
Ending Balance, Amount at Jun. 30, 2018	(1,087,623)	7,533,947	69,742	(8,693,671)	$ 2,359
Beginning Balance, Shares at Sep. 30, 2018					236,046,151
Beginning Balance, Amount at Sep. 30, 2018	(819,214)	7,972,361	92,046	(8,885,981)	$ 2,360
Shares issued in connection with the sale of common stock, Shares					5,084,525
Shares issued in connection with the conversion of note payable, Shares					509,091
Terminal balance of derivative liability	28,992	28,992
Foreign currency translation adjustment	30,352		30,352
Net Loss	(954,507)			(954,507)
Stock-based compensation expense, Shares					600,000
Shares issued in connection with the sale of common stock, Amount	845,000	844,949			$ 51
Shares issued in connection with the conversion of note payable, Amount	41,818	41,813			5
Stock-based compensation expense, Amount	100,200	100,194			$ 6
Ending Balance, Shares at Mar. 31, 2019					238,861,939
Ending Balance, Amount at Mar. 31, 2019	(830,681)	8,425,626	136,902	(9,395,598)	$ 2,389
Shares issued in connection with the sale of common stock, Shares					3,014,192
Shares issued in connection with the conversion of note payable, Shares					363,636
Terminal balance of derivative liability	42,716	42,716
Foreign currency translation adjustment	(14,504)		(14,504)
Net Loss	(444,890)			(444,890)
Shares issued in connection with the sale of common stock, Amount	500,000	499,970			30
Shares issued in connection with the conversion of note payable, Amount	20,000	19,997			$ 3
Ending Balance, Shares at Jun. 30, 2019					242,239,767
Ending Balance, Amount at Jun. 30, 2019	$ (727,359)	$ 8,988,309	$ 122,398	$ (9,840,488)	$ 2,422